Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Free Cash Flow (2016 - 2026)

Aytu Biopharma has reported Free Cash Flow over the past 15 years, most recently at $3.7 million for Q4 2025.

  • Quarterly Free Cash Flow rose 26.18% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$698000.0 through Dec 2025, down 445.54% year-over-year, with the annual reading at -$2.2 million for FY2025, 26.09% down from the prior year.
  • Free Cash Flow was $3.7 million for Q4 2025 at Aytu Biopharma, up from -$618000.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $9.4 million in Q2 2023 and troughed at -$9.1 million in Q3 2022.
  • The 5-year median for Free Cash Flow is -$1.1 million (2024), against an average of -$1.5 million.
  • Year-over-year, Free Cash Flow surged 2247.41% in 2024 and then tumbled 2468.5% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$8.8 million in 2021, then surged by 72.21% to -$2.5 million in 2022, then surged by 94.49% to -$135000.0 in 2023, then surged by 2247.41% to $2.9 million in 2024, then grew by 26.18% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Free Cash Flow are $3.7 million (Q4 2025), -$618000.0 (Q3 2025), and $2.8 million (Q2 2025).